SBIR/STTR Research Award

Use of Highly Porous Polymer Beads to Remove Anti-A and Anti-B Antibodies from Plasma for Transfusion

Award identifier e0c35621ae15d14247b9c2b01d125290a478819a5b9ee675521b2977b23cd70eAwarding agency Department of Defense · Defense Health Agency

Award amount

$999,070

Program and phase

STTR · Phase II

Award year

2017

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Defense
Branch
Defense Health Agency
Recipient company
CYTOSORBENTS MEDICAL INC
Proposal award date
2017-05-15
Contract end date
2019-10-14
UEI
LSF2KFUSY4K7
Solicitation number
2015.0
Topic code
DHP15B-001

Research abstract

Plasma from AB donors is considered universal as it can be transfused regardless of recipient blood type and is frequently used to rapidly resuscitate massively bleeding hospital trauma patients and warfighters with combat casualties. However supplies can be rapidly depleted as AB donors make up only 4% of the population. Therefore robust a technology to cost-effectively generate universal plasma from any donor is of great importance. We propose the development of a light-weight, biocompatible filter, composed of a highly porous polymer to remove anti-A and anti-B antibodies from plasma. This small, light-weight filter will convert the plasma from donors of any blood type into universal plasma while maintaining levels of beneficial plasma factors without the use of expensive, complex biological ligands that could degrade or leach from the column. The outcome will be the development of a safe, easy-to-use, cost-effective filter that can simplify logistics, reduce transfusion costs and eliminate risk from transfusion errors caused by ABO incompatibility, providing a significant clinical benefit to patients treated at emergency trauma centers but particularly for logistically-constrained, advanced military surgical units. The widespread availability of universal plasma has the potential to significantly advance early resuscitative treatment protocols for massive trauma patients.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

16 SBIR/STTR records share this UEI (2012–2023). Reported award amounts total $11,830,667. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, Department of Health and Human Services

Agency intelligence

Department of Defense

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.